
Hijacker parasite blocked from infiltrating blood
A major international collaboration led by Melbourne researchers has discovered that the world’s most widespread malaria parasite infects humans by hijacking a protein the body cannot live without.
The researchers were then able to successfully develop antibodies that disabled the parasite from carrying out this activity.
The study, led by the Walter and Eliza Hall Institute’s Associate Professor Wai-Hong Tham and Dr Jakub Gruszczyk, found that the deadly malaria parasite Plasmodium vivax (P. vivax) causes infection through latching onto the human transferrin receptor protein, which is crucial for iron delivery into the body’s young red blood cells.
Published today in Science, the discovery has solved a mystery that researchers have been grappling with for decades.
Associate Professor Tham, who is also a HHMI-Wellcome International Research Scholar, said the collective efforts of teams from Australia, New Zealand, Singapore, Thailand, United Kingdom, United States, Brazil and Germany had brought the world closer to a potential effective vaccine against P.vivax malaria.
“P. vivax currently inflicts a huge burden on global health. It is the most common malaria parasite in countries outside of Africa, with more than 16 million clinical cases recorded each year.
“The parasite can lie dormant in the liver for months on end without causing any symptoms, which makes it very sneaky and difficult to treat,” Associate Professor Tham said.
“We now know that P. vivax is hijacking the human transferrin receptor which is essential for transporting iron into the body’s young red blood cells.
“Being able to stop P. vivax from latching onto this receptor and infliltrating the blood is a major breakthrough and important step towards malaria elimination,” she said.

Dr Gruszczyk said once the teams understood how the parasite was gaining entry into the cells, they were able to design antibodies to block the mode of access.
“Using the Australian Synchrotron in Melbourne, we generated a 3D map of the parasite protein which is the mechanism P. vivax uses to latch onto the human transferrin receptor and enter the young red blood cells.
“This map provided an unprecedented view of the parasite protein’s shape, which guided the design of antibodies to block P. vivax from gaining entry into the human cells,” Dr Gruszczyk said.

Associate Professor Tham said they were thrilled to see the antibodies successfully block P. vivax invasion using parasites from both Thailand and Brazil. “We are now looking to include collaborative partners in the Pacific, so we can further test the effectiveness of our antibodies,” she said.
Study collaborator Dr Jonathan Abraham from Harvard University said the results of the new study aligned with a growing body of evidence that could be used to target multiple infectious diseases.
“Transferrin receptor is also co-opted by five viruses that cause Ebola-like diseases in South America. These diseases are known as New World haemorrhagic fevers.
“Our increasing understanding of how several pathogens are taking advantage of transferrin receptor, means we are getting closer to disrupting infection for a number of deadly diseases,” Dr Abraham said.
Learn more: Hijacker parasite blocked from infiltrating blood
The Latest on: Malaria parasite
[google_news title=”” keyword=”malaria parasite” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
- Malaria: Three-dose Plasmodium falciparum sporozoite (PfSPZ) vaccine shows safety, efficacy in Burkina Faso adultson January 8, 2023 at 4:19 am
NewsDesk @bactiman63 A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults ...
- Non-invasive malaria screening device uses light for diagnosison January 6, 2023 at 9:58 am
The test, being developed by a research team led by a Hopkins engineer, is seen as an alternative to current rapid tests that require blood draws ...
- 3-Dose Malaria Vaccine Shows Promise in African Trialon January 6, 2023 at 4:24 am
Our study shows that the vaccine can be given to malaria-experienced adults in a highly endemic area and still provide protection, which is difficult and complicated as these i ...
- A three-dose malaria vaccine shows safety, efficacy in West African adultson January 5, 2023 at 6:01 am
A three-dose regimen of a whole-parasite vaccine against malaria -- called Plasmodium falciparum sporozoite (PfSPZ) vaccine -- demonstrated safety and efficacy when tested in adults living in Burkina ...
- Study demonstrates safety and efficacy of a three-dose whole-parasite vaccine against malariaon January 4, 2023 at 3:45 pm
A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in ...
- Malaria Pipeline Clinical Trials Featuring 35+ companies| DelveInsighton January 4, 2023 at 9:00 am
Malaria Pipeline Clinical Trials Featuring 35+ companies| DelveInsight Malaria is one of the most widespread life-threatening diseases, commonly occurring in ...
- The end of malaria? A new vaccine from the team that cracked Covidon January 3, 2023 at 12:02 pm
This is when mosquitoes proliferate, along with the malaria-causing parasites they carry in their saliva. “We have one of the highest rates of exposure in the world,” says Stephen Chakaya ...
- The end of malaria? A new vaccine from the team that cracked Covidon December 31, 2022 at 4:00 pm
Anzazi Saidi sits on a bench under a sign proclaiming “Celebrate life! Use family planning”. She looks exhausted as she waits to see a nurse. Wrapped in a red-d ...
- Last man standing: why the malaria parasite may be getting tougher all the timeon December 30, 2022 at 12:00 am
An ‘unusual’ malaria outbreak in Laos has highlighted the threat of drug-resistance in countries edging closer to elimination ...
- How malaria parasite can be eradicated – UNIMEDon December 27, 2022 at 9:50 pm
A professor of Cellular and Molecular Parasitology, Roseangela Nwuba, has identified persistence, and good intelligence information as ways to eradicate the malaria parasite in society.
via Google News and Bing News